Organogenesis Holdings Inc. (ORGO) Profit Margin
Organogenesis Holdings Inc. (ORGO) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -0.15% |
| 2017-12-31 | -4.23% |
| 2018-12-31 | -33.51% |
| 2019-12-31 | -15.50% |
| 2020-12-31 | 5.09% |
| 2021-12-31 | 20.16% |
| 2022-12-31 | 3.44% |
| 2023-12-31 | 1.14% |
| 2024-12-31 | 0.18% |
| 2025-12-31 | 6.56% |
How ORGO compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| NVAX | Novavax Inc. | 39.19% |
| GILD | Gilead Sciences Inc. | 28.90% |
| EBS | Emergent BioSolutions Inc. | 7.08% |
| ARWR | Arrowhead Pharmaceuticals Inc. | -0.20% |
| ACHV | Achieve Life Sciences Inc. | -24.38% |
These are five companies in the same sector as ORGO with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Organogenesis Holdings Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("ORGO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ORGO | $1.70 | +3.99% | 0.33M |
| 3 | ||||
| 4 | ||||
| 5 |